Cross-reactivity of T cell lines and clones to beta-lactam antibiotics

被引:0
|
作者
MauriHellweg, D
Zanni, M
Frei, E
Bettens, F
Brander, C
Mauri, D
Padovan, E
Weltzien, HU
Pichler, WJ
机构
[1] INSELSPITAL BERN,INST IMMUNOL & ALLERGOL,CH-3010 BERN,SWITZERLAND
[2] MAX PLANCK INST IMMUNOBIOL,FREIBURG,GERMANY
来源
JOURNAL OF IMMUNOLOGY | 1996年 / 157卷 / 03期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To clarify on a molecular level the specific T cell response to haptens like penicillin G, we generated T cell lines and clones from penicillin-allergic patients, Two types of beta-lactam reactivity of T cells could be delineated: one group of patients showed a rather restricted specificity, as the penicillin-elicited T cell lines generated from such donors proliferated only to the stimulating penicillin, but not to other beta-lactam antibiotics nor to cephalosporines, even if the side chain was identical, This indicates that the penicilloyl structure together with the side chain was recognized by these T cells, The second group comprised patients with more broadly reactive T cells, as they were restimulated by penicillin G as well as by related penicillins like amoxicillin or ampicillin, but not cephalosporines. This indicates that the penicilloyl structure, a common motif of penicillins, was important for T cell recognition, Clones generated from a broadly reactive patient confirmed this heterogeneity, as either monospecific or broadly specific T cell clones could be identified, This broad or very restricted pattern of T cell reactivity was reflected in the use of TCR V beta-chains: while the broadly reactive T cell lines showed a heterogenous TCR usage, the highly restricted T cell lines showed an up regulation of one TCR V beta-chain, Thus, our data suggest that the outgrowth of T cells bearing a certain TCR V beta may be a sign of a limited cross-reactivity.
引用
收藏
页码:1071 / 1079
页数:9
相关论文
共 50 条
  • [31] Tuberculosis and beta-lactam antibiotics
    Gun, Mehmet Akif
    Bozdogan, Bulent
    Coban, Ahmet Yilmaz
    FUTURE MICROBIOLOGY, 2020, 15 (10) : 937 - 944
  • [32] MODERN BETA-LACTAM ANTIBIOTICS
    SYKES, RB
    BONNER, DP
    SWABB, EA
    PHARMACOLOGY & THERAPEUTICS, 1985, 29 (03) : 321 - 352
  • [33] Newer beta-lactam antibiotics
    Chandrasekar, PH
    Alangaden, GJ
    CURRENT OPINION IN INFECTIOUS DISEASES, 1996, 9 (06) : 391 - 397
  • [34] ALLERGY TO BETA-LACTAM ANTIBIOTICS
    SHEPHERD, GM
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1991, 11 (03) : 611 - 633
  • [35] POSITIONING OF THE BETA-LACTAM ANTIBIOTICS
    STILLE, W
    INFECTION, 1985, 13 : S7 - S8
  • [36] COMBINATIONS OF BETA-LACTAM ANTIBIOTICS
    PEDLER, SJ
    BINT, AJ
    BRITISH MEDICAL JOURNAL, 1984, 288 (6423): : 1022 - 1024
  • [37] NEW BETA-LACTAM ANTIBIOTICS
    VERBIST, L
    ACTA CLINICA BELGICA, 1980, 35 (06): : 333 - 338
  • [38] SYNTHESIS OF BETA-LACTAM ANTIBIOTICS
    BALDWIN, JE
    HESSON, D
    HABER, S
    HERCHEN, S
    CHRISTIE, M
    KRUSE, L
    KITCHEN, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1977, 173 (MAR20): : 48 - 48
  • [39] Beta-lactam antibiotics and Painkillers
    von Kieseritzky, Kathrin
    Allergo Journal, 2016, 25 (07) : 54 - 54
  • [40] FORMATION OF BETA-LACTAM ANTIBIOTICS
    DEMAIN, AL
    RIVISTA DI BIOLOGIA-BIOLOGY FORUM, 1983, 76 (02): : 225 - 244